Novel mechanism of action of ACE and its inhibitors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Carretero, Oscar A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KININ; SERASPENIDE; TRANSCRIPTION FACTOR AP 1;

AGING; ANTIHYPERTENSIVE ACTIVITY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; VASCULAR DISEASE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; HEMODYNAMIC PROCESSES; HUMANS; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, BRADYKININ B2;

EID: 27144487798     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00781.2005     Document Type: Editorial

References (15)

1. Carretero OA, Yang XP, and Rhaleb NE. The kallikrein-kinin system as a regulator of cardiovascular and renal function. In: Hypertension: A Companion to Brenner and Rector's The Kidney, edited by Oparil S and Weber MA. Philadelphia, PA: Elsevier, 2005, p. 203-218.
2. Erdös EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K Dahl memorial lecture. Hypertension 16: 363-370, 1990.
3. Hecker M, Blaukat A, Bara AT, Müller-Esterl W, and Busse R. ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br J Pharmacol 121: 1475-1481, 1997.
4. Hecker M, Pörsti I, Bara AT, and Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br J Pharmacol 111: 238-244, 1994.
5. Ignjacev I, Kintsurashvili E, Johns C, Vitseva O, Duka A, Gavras I, and Gavras H. Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol 289: H1814-H1820, 2005.
6. 1 receptor by ACE inhibitors. Int Immunopharmacol 2: 1787-1793, 2002.
7. Kohlstedt K, Busse R, and Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension 45: 126-132, 2005.
8. Kohlstedt K, Shoghi F, Müller-Esterl W, Busse R, and Fleming I. CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circ Res 91: 749-756, 2002.
9. Kondoh G, Tojo H, Nakatani Y, Komazawa N, Murata C, Yamagata K, Maeda Y, Kinoshita T, Okabe M, Taguchi R, and Takeda J. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nat Med 11: 160-166, 2005.
10. Minshall RD, Erdös EG, and Vogel SM. Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation. Am J Cardiol 80: 132A-136A, 1997.
11. Minshall RD, Tan F, Nakamura F, Rabito SF, Becker RP, Marcic B, and Erdös EG. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin 82 receptors and angiotensin I-converting enzyme in CHO cells. Circ Res 81: 848-856, 1997.
12. Peng H, Carretero OA, Raij L, Yang F, Kapke A, and Rhaleb NE. Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension 37: 794-800, 2001.
13. Peng H, Carretero OA, Vuljaj N, Liao T-D, Motivala A, Peterson EL, and Rhaleb N-E. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation. In press.
14. Rasoul S, Carretero OA, Peng H, Cavasin MA, Zhuo J, Sanchez-Mendoza A, Brigstock DR, and Rhaleb N-E. Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension. J Hypertens 22: 593-603, 2004.
15. Rhaleb N-E, Peng H, Yang X-P, Liu Y-H, Mehta D, Ezan E, and Carretero OA. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Circulation 103: 3136-3141, 2001.